Chris Tennant

Chris Tennant has a diverse work experience in the field of medical writing. Chris is currently serving as the Head of Medical Writing at Intellia Therapeutics, Inc since June 2021. Prior to this, they worked as the Sr. Director of Medical Writing at Pfizer from August 2019 to June 2021. Chris also has experience working as the Director of Medical Writing at Array BioPharma from October 2008 to August 2019. Before joining Array BioPharma, they founded their own consulting firm called Tennant Biomedical Consulting, where they served as the President from January 2006 to October 2008.

Chris Tennant attended the University of Maryland, but no specific details about their degree, field of study, start year, or end year are provided.